Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00022191
Status:
COMPLETED
Last Update Posted:
2013-06-12
First Post:
2001-08-10
Brief Title:
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Organization Data
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Class:
NETWORK
Study ID:
EORTC-30987
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Medical Research Council | OTHER_GOV |
| National Cancer Institute NCI | NIH |
| Groupe DEtude des Tumeurs Uro-Genitales | OTHER |
| Institute of Cancer Research United Kingdom | OTHER |
| Central European Cooperative Oncology Group | OTHER |
| NCIC Clinical Trials Group | NETWORK |
| SWOG Cancer Research Network | NETWORK |
| German Association of Urologic Oncology | OTHER |
| Spanish Oncology Genito-Urinary Group | OTHER |